[go: up one dir, main page]

EA199900256A1 - Нуклеотидная и белковая последовательность маммастатина и способы применения - Google Patents

Нуклеотидная и белковая последовательность маммастатина и способы применения

Info

Publication number
EA199900256A1
EA199900256A1 EA199900256A EA199900256A EA199900256A1 EA 199900256 A1 EA199900256 A1 EA 199900256A1 EA 199900256 A EA199900256 A EA 199900256A EA 199900256 A EA199900256 A EA 199900256A EA 199900256 A1 EA199900256 A1 EA 199900256A1
Authority
EA
Eurasian Patent Office
Prior art keywords
mammastatin
cells
phosphorylated
breast
express
Prior art date
Application number
EA199900256A
Other languages
English (en)
Inventor
Пол Р. мл. Эрвин
Original Assignee
Байотерапиз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байотерапиз, Инк. filed Critical Байотерапиз, Инк.
Publication of EA199900256A1 publication Critical patent/EA199900256A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Нуклеотидная последовательность, кодирующая Маммастатин, специфический ингибитор роста клеток молочной железы. Маммастатин кодируется единственной последовательностью нуклеиновой кислоты и имеет приблизительную молекулярную массу 44 кД в его неактивной, нефосфорилированной форме. Нормальные клетки молочной железы экспрессируют функциональные фосфорилированные формы, имеющие приблизительные молекулярные массы 53 кД и 49 кД. Клетки метастазов молочной железы либо не экспрессируют Маммастатин вообще, либо не экспрессируют фосфорилированные формы 53 кД и 49 кД. Рост клеток рака молочной железы ингибируется посредством введения фосфорилированного Маммастатина.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199900256A 1996-10-03 1997-10-03 Нуклеотидная и белковая последовательность маммастатина и способы применения EA199900256A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2731596P 1996-10-03 1996-10-03
PCT/US1997/018026 WO1998014577A2 (en) 1996-10-03 1997-10-03 Nucleotide and protein sequence of mammastatin and methods of use

Publications (1)

Publication Number Publication Date
EA199900256A1 true EA199900256A1 (ru) 2000-02-28

Family

ID=21836977

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900256A EA199900256A1 (ru) 1996-10-03 1997-10-03 Нуклеотидная и белковая последовательность маммастатина и способы применения

Country Status (8)

Country Link
US (6) US6451765B1 (ru)
EP (2) EP1935899A1 (ru)
JP (2) JP4452331B2 (ru)
AU (1) AU733380B2 (ru)
BR (1) BR9713248A (ru)
CA (1) CA2267095C (ru)
EA (1) EA199900256A1 (ru)
WO (1) WO1998014577A2 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998014577A2 (en) * 1996-10-03 1998-04-09 Biotherapies, Inc. Nucleotide and protein sequence of mammastatin and methods of use
US6500937B1 (en) 1996-10-03 2002-12-31 University Of Michigan Nucleotide sequence encoding a mammary cell growth inhibitor
US6939714B2 (en) 1999-06-18 2005-09-06 Biotherapies, Inc. Epithelial cell growth inhibitors
JP2003513615A (ja) * 1999-06-18 2003-04-15 バイオセラピーズ・インコーポレイテッド 上皮細胞増殖インヒビター
NZ537920A (en) 1999-06-28 2006-10-27 Genentech Inc An isolated Apo-2 ligand variant polypeptide comprising an amino acid sequence which differs from the native sequence Apo-2 ligand
US20030212263A1 (en) * 2000-06-19 2003-11-13 The University Of Michigan Mammastatin sequence variant C
AU2000257514A1 (en) * 2000-06-19 2002-01-02 The University Of Michigan Mammastatin sequence variant c
EP3866825A1 (en) * 2018-10-19 2021-08-25 Translate Bio, Inc. Pumpless encapsulation of messenger rna

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4379839A (en) 1977-05-23 1983-04-12 The Trustees Of Columbia University In The City Of New York Method for detecting cancer
US4753894A (en) 1984-02-08 1988-06-28 Cetus Corporation Monoclonal anti-human breast cancer antibodies
EP0414807A4 (en) * 1988-05-20 1991-07-03 The Regents Of The University Of Michigan Human mammary cell growth inhibitor and methods of production and use
WO1989011491A1 (en) * 1988-05-20 1989-11-30 The Regents Of The University Of Michigan Antibodies to human mammary cell growth inhibitor and methods of production and use
WO1998014577A2 (en) * 1996-10-03 1998-04-09 Biotherapies, Inc. Nucleotide and protein sequence of mammastatin and methods of use
US6500937B1 (en) * 1996-10-03 2002-12-31 University Of Michigan Nucleotide sequence encoding a mammary cell growth inhibitor

Also Published As

Publication number Publication date
US20110039279A1 (en) 2011-02-17
US7332287B2 (en) 2008-02-19
US20090011434A1 (en) 2009-01-08
US20020072592A1 (en) 2002-06-13
EP1935899A1 (en) 2008-06-25
CA2267095C (en) 2010-08-10
WO1998014577A3 (en) 1998-04-09
US6492504B2 (en) 2002-12-10
US20030095972A1 (en) 2003-05-22
JP2001502533A (ja) 2001-02-27
BR9713248A (pt) 2000-01-18
US7323173B2 (en) 2008-01-29
CA2267095A1 (en) 1998-04-09
AU733380B2 (en) 2001-05-10
US20030108961A1 (en) 2003-06-12
JP4452331B2 (ja) 2010-04-21
EP0929675A2 (en) 1999-07-21
US6451765B1 (en) 2002-09-17
JP2010031013A (ja) 2010-02-12
WO1998014577A2 (en) 1998-04-09
AU4670997A (en) 1998-04-24

Similar Documents

Publication Publication Date Title
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
DE60033138D1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
EA199700447A1 (ru) Последовательность днк и кодируемый ею специфический для молочной железы белок карциномы молочной железы
ES2137931T3 (es) Proteinas gdf-1 y uog-1.
DE69828193D1 (de) Hyaluronan synthase gen und seine verwendung
DE69833784D1 (de) Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren
DE69942861D1 (de) Ldcam genannte moleküle
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
ATE415480T1 (de) B7l-1 moleküle
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
ATE414775T1 (de) Polypeptide mit prolyldipeptidylaminopeptidase- aktivität und dafür kodierende nukleinsäuren
DE69333346D1 (de) Neuartiges p- selectin ligandenprotein
DE69535696D1 (de) Tripeptidyl-aminopeptidase
DE60043428D1 (de) POLYPEPTIDE MIT VERZWEIGUNGSENZYM-AKTIVITäT UND FüR DIESE KODIERENDE NUKLEINSäUREN
EA199900256A1 (ru) Нуклеотидная и белковая последовательность маммастатина и способы применения
ATE364706T1 (de) Nukleotid- und proteinsequenz von mammastatin und anwendungsmethoden
ATE214427T1 (de) Chimäre msp und daf proteine mit einem telloberflächenlokalisierendem domän
IL78270A0 (en) Dedicated ribosomes and their use
DK1032683T3 (da) Polypeptider med 5-aminolevulinsyre-syntase-aktivitet og nukleinsyrer, der koder for disse
PT1007647E (pt) Expressao de ingap em niveis elevados
DE60026049D1 (de) POLYPEPTIDE MIT GLUCANOTRANSFERASE AKTIVITÄT UND DAFüR KODIERENDE NUKLEINSÄUREN
EA200100440A1 (ru) Ген prv-1 и его применение
EA200200286A1 (ru) Ген prv-1 и его применение
DE69939587D1 (en) Semaphorin polypeptide
SE9604439D0 (sv) New receptor